Free Trial

Insider Selling: Lemonade (NYSE:LMND) Insider Sells 223 Shares of Stock

Lemonade logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Insider sale: Director Maya Prosor sold 223 shares on March 3 at an average price of $50.12 for $11,176.76, leaving her with 7,404 shares (a 2.92% reduction in her holding).
  • Stock context: Lemonade (NYSE:LMND) traded around $55.04 (up ~0.5%), has a market cap of about $4.2 billion, a 1‑year range of $24.31–$99.90, and a negative P/E of -24.35.
  • Fundamentals and analyst view: Lemonade reported a loss per share of $0.29, beating estimates (‑$0.41) with revenue up 53.3% year‑over‑year, but it still posts negative margins; analysts’ consensus is an average "Hold" rating with a $68.75 price target.
  • Interested in Lemonade? Here are five stocks we like better.

Lemonade, Inc. (NYSE:LMND - Get Free Report) insider Maya Prosor sold 223 shares of the company's stock in a transaction on Tuesday, March 3rd. The shares were sold at an average price of $50.12, for a total transaction of $11,176.76. Following the completion of the transaction, the insider owned 7,404 shares of the company's stock, valued at $371,088.48. This represents a 2.92% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Lemonade Stock Up 0.5%

NYSE:LMND traded up $0.27 during trading hours on Thursday, reaching $55.04. 1,961,348 shares of the company's stock were exchanged, compared to its average volume of 2,817,813. The company has a 50-day moving average of $73.07 and a 200 day moving average of $66.28. Lemonade, Inc. has a 1-year low of $24.31 and a 1-year high of $99.90. The firm has a market capitalization of $4.20 billion, a price-to-earnings ratio of -24.35 and a beta of 2.12.

Lemonade (NYSE:LMND - Get Free Report) last released its earnings results on Wednesday, February 18th. The company reported ($0.29) EPS for the quarter, beating analysts' consensus estimates of ($0.41) by $0.12. Lemonade had a negative return on equity of 31.19% and a negative net margin of 22.43%.During the same period in the prior year, the company earned ($0.42) earnings per share. The company's quarterly revenue was up 53.3% compared to the same quarter last year. Research analysts forecast that Lemonade, Inc. will post -3.03 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Caitong International Asset Management Co. Ltd increased its stake in shares of Lemonade by 8,080.0% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 409 shares of the company's stock valued at $29,000 after acquiring an additional 404 shares in the last quarter. Bayforest Capital Ltd acquired a new position in shares of Lemonade during the third quarter valued at about $25,000. Northwestern Mutual Wealth Management Co. bought a new position in shares of Lemonade during the 4th quarter worth about $33,000. Torren Management LLC acquired a new stake in shares of Lemonade in the 4th quarter valued at about $35,000. Finally, Strive Financial Group LLC bought a new stake in Lemonade in the 4th quarter valued at about $38,000. Institutional investors own 80.30% of the company's stock.

Wall Street Analyst Weigh In

LMND has been the topic of several research reports. Wolfe Research set a $44.00 price objective on shares of Lemonade in a research note on Tuesday, February 24th. Cantor Fitzgerald lifted their target price on shares of Lemonade from $85.00 to $92.00 and gave the stock an "overweight" rating in a report on Wednesday, January 14th. Morgan Stanley set a $85.00 target price on shares of Lemonade and gave the stock an "equal weight" rating in a research report on Tuesday, December 16th. Citigroup reaffirmed an "outperform" rating on shares of Lemonade in a research report on Friday, January 16th. Finally, Piper Sandler set a $65.00 price objective on Lemonade in a research note on Thursday, February 19th. Four research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $68.75.

Get Our Latest Stock Report on Lemonade

About Lemonade

(Get Free Report)

Lemonade, Inc NYSE: LMND is a New York–based technology-driven insurance carrier that leverages artificial intelligence and behavioral economics to streamline the purchase and management of policies. Founded in 2015, the company offers renters, homeowners, pet, term life and car insurance products tailored for digitally savvy consumers. By automating underwriting and claims processing through chatbots and machine learning, Lemonade aims to deliver a more transparent and user-friendly experience than traditional insurers.

The company's product suite includes standalone policies for renters and homeowners, customizable pet insurance plans, and term life coverage with simple online applications.

See Also

Insider Buying and Selling by Quarter for Lemonade (NYSE:LMND)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Lemonade Right Now?

Before you consider Lemonade, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lemonade wasn't on the list.

While Lemonade currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines